RBMS2 and nonpapillary renal cell carcinoma: The CCK-8 assay results demonstrated that overexpressing RBMS2 significantly inhibited the proliferation capacity of both 786-O and Caki-2 ccRCC cell lines (Figures 5(a) and 5(b)).